Viewing Study NCT06577623


Ignite Creation Date: 2025-12-18 @ 8:16 AM
Ignite Modification Date: 2025-12-18 @ 8:16 AM
Study NCT ID: NCT06577623
Status: None
Last Update Posted: 2024-08-30 00:00:00
First Post: 2024-08-27 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: In-Person Mindfulness-based Intervention for Adolescents with Autism Spectrum Disorder and Their Caregivers
Sponsor: None
Organization:

Study Overview

Official Title: In-Person Mindfulness-based Intervention for Adolescents with Autism Spectrum Disorder and Their Caregivers
Status: None
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Adolescents with ASD and their parents will complete a 3-hour in-person screening visit to determine eligibility for the study.

Adolescents with ASD and their caregivers will participate in an 8-week mindfulness-based group intervention that meets once weekly at SARRC in Phoenix, Arizona. Each meeting will last approximately 2-hours. Teens and parents/caregivers will have separate meetings with separate group leaders but will reunite for approximately 15-minutes as a larger group to review home practice for the upcoming week. Teens and parents will each be given a free 1-year subscription to Ten Percent Happier, a commercially available mobile app focused on mindfulness meditations. Each week teens will be assigned home practice, which means we will ask participants to practice mindfulness meditation every day. The investigators will recommend specific meditations and activities to complete, but participants will have access to all mindfulness meditations on the Ten Percent Happier app.

Teens and caregivers will be asked to complete questionnaires assessing things like mood, anxiety, quality of life, mindfulness in day-to-day life, and their perception of the intervention. These questionnaires will be done immediately before the intervention, immediately after completing the intervention, and at 2-month follow-up.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: